Ignite Creation Date:
2025-12-24 @ 6:51 PM
Ignite Modification Date:
2026-02-25 @ 5:52 PM
Study NCT ID:
NCT02911857
Status:
COMPLETED
Last Update Posted:
2018-08-20
First Post:
2016-09-20
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Extention Study of Safety of Canakinumab in Japanese Patients With Periodic Fever Syndromes
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-10-03
Start Date Type:
ACTUAL
Primary Completion Date:
2017-01-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-01-27
Completion Date Type:
ACTUAL
First Submit Date:
2016-09-20
First Submit QC Date:
None
Study First Post Date:
2016-09-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-07-25
Results First Submit QC Date:
None
Results First Post Date:
2018-08-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-11-30
Last Update Post Date:
2018-08-20
Last Update Post Date Type:
ACTUAL